Weight loss, heart protection, kidney protection and more recently brain protectionand of course, anti-ageing - the long (and growing list) of benefits of the drugs pumped out by Danish Pharma, Novo Nordisk and US Pharma, Lilly
It's whether the evidence of benefit outweighs the evidence of harm at a population scale, across diverse patients, over meaningful time horizons
We are only just beginning to understand the full impact of GLP-1s, but a world of possibility already awaits and with the market for these drugs expected to reach around 31.5 million US consumers by 2035, every brand will need a GLP-1 strategy
Due to its effects as a competitive inhibitor of numerous 2-oxoglutarate and Fe 2+ -dependent dioxygenases, 2-HG is referred to as an oncometabolite
Epstein-Barr virus infection
Your provider can help create a transition plan to maintain your progress